Stephen George Dilly's Net Worth

$22.4 Million

Estimate Recalculated Dec 15, 2025 11:19AM EST

Who is Stephen George Dilly

Stephen George Dilly has an estimated net worth of $22.4 Million. This is based on reported shares across multiple companies, which include CODEXIS, INC., SANGAMO BIOSCIENCES INC, Sierra Oncology, Inc., Aimmune Therapeutics, Inc., and AVIGEN INC \DE.

SEC CIK

Stephen George Dilly's CIK is 0001389147

Past Insider Trading and Trends

2018 was Stephen George Dilly's most active year for acquiring shares with 9 total transactions. Stephen George Dilly's most active month to acquire stocks was the month of May. 2018 was Stephen George Dilly's most active year for disposing of shares, totalling 17 transactions. Stephen George Dilly's most active month to dispose stocks was the month of May. 2018 saw Stephen George Dilly paying a total of $906,630.00 for 317,500 shares, this is the most they've acquired in one year. In 2017 Stephen George Dilly cashed out on 400,000 shares for a total of $10,562,715.09, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CODEXIS, INC.

See Remarks
Updated Jan 02, 2024
1.44MJan 01
Sep 08
Feb 08 - Mar 08
483.97KFeb 21
700.00KAug 01
33.97KJun 14
22.70KJun 15
17.91KJun 16
Showing 9 results

SANGAMO THERAPEUTICS, INC

Investor
Updated Jun 03, 2020
Form 4/A35.00KMay 18
22.50KMay 18
ScheduledMar 19
ScheduledMar 16
20.00KJun 10
17.50KJun 11
10.00KJun 05
10.00KJun 14
10.00KJun 22
10.00KApr 21
10.00KJun 12
10.00KJun 21
10.00KJun 01
50.00KMar 31
Showing 15 results

Sierra Oncology, Inc.

CEO and President
Updated Jul 01, 2022
Jul 01
65.00KJun 17
165.00KMar 14
65.00KJan 28
May 19
92.00KMar 15
520.00KJun 01
Showing 8 results

Aimmune Therapeutics, Inc.

President and CEO
Updated Jun 13, 2018
ScheduledJun 11
ScheduledJun 06 - Jun 08
ScheduledOct 12 - Jun 05
ScheduledOct 23
ScheduledOct 16
ScheduledOct 04 - Oct 06
ScheduledAug 23 - Sep 25
ScheduledJul 26
ScheduledJun 23
ScheduledMay 10
1.09MFeb 24
ScheduledJul 25 - Nov 11
1.14MFeb 26
897.01K
Showing 14 results

AVIGEN INC \DE

Investor
Updated Dec 21, 2009
Dec 18
20.00KMay 19
6.67KMay 30
30.00KFeb 05
Showing 5 results